nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—ABCG2—Sulfasalazine—ankylosing spondylitis	0.349	0.526	CbGbCtD
Clofarabine—ABCG2—Dexamethasone—ankylosing spondylitis	0.174	0.263	CbGbCtD
Clofarabine—ABCG2—Methotrexate—ankylosing spondylitis	0.14	0.211	CbGbCtD
Clofarabine—DCK—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.00141	0.0885	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.00139	0.0871	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Betamethasone—ankylosing spondylitis	0.00139	0.0871	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.00137	0.0859	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.00136	0.0851	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Betamethasone—ankylosing spondylitis	0.00135	0.0846	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Dexamethasone—ankylosing spondylitis	0.00135	0.0846	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Triamcinolone—ankylosing spondylitis	0.00132	0.0826	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Prednisone—ankylosing spondylitis	0.00129	0.0808	CbGdCrCtD
Clofarabine—DCK—Desoximetasone—Prednisolone—ankylosing spondylitis	0.00126	0.0789	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Prednisone—ankylosing spondylitis	0.00125	0.0784	CbGdCrCtD
Clofarabine—DCK—Diflorasone—Prednisolone—ankylosing spondylitis	0.00122	0.0765	CbGdCrCtD
Clofarabine—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.000843	0.00263	CcSEcCtD
Clofarabine—Haemoglobin—Betamethasone—ankylosing spondylitis	0.000843	0.00263	CcSEcCtD
Clofarabine—Irritability—Methotrexate—ankylosing spondylitis	0.000842	0.00263	CcSEcCtD
Clofarabine—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000839	0.00262	CcSEcCtD
Clofarabine—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000839	0.00262	CcSEcCtD
Clofarabine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000837	0.00261	CcSEcCtD
Clofarabine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000833	0.0026	CcSEcCtD
Clofarabine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000831	0.00259	CcSEcCtD
Clofarabine—Weight decreased—Prednisone—ankylosing spondylitis	0.000826	0.00257	CcSEcCtD
Clofarabine—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000808	0.00252	CcSEcCtD
Clofarabine—Erythema—Triamcinolone—ankylosing spondylitis	0.000805	0.00251	CcSEcCtD
Clofarabine—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.000803	0.0025	CcSEcCtD
Clofarabine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000803	0.0025	CcSEcCtD
Clofarabine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000797	0.00249	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000794	0.00248	CcSEcCtD
Clofarabine—Back pain—Triamcinolone—ankylosing spondylitis	0.000778	0.00243	CcSEcCtD
Clofarabine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000761	0.00237	CcSEcCtD
Clofarabine—Angiopathy—Betamethasone—ankylosing spondylitis	0.000761	0.00237	CcSEcCtD
Clofarabine—Hypertension—Prednisolone—ankylosing spondylitis	0.000755	0.00236	CcSEcCtD
Clofarabine—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000748	0.00233	CcSEcCtD
Clofarabine—Alopecia—Betamethasone—ankylosing spondylitis	0.000741	0.00231	CcSEcCtD
Clofarabine—Alopecia—Dexamethasone—ankylosing spondylitis	0.000741	0.00231	CcSEcCtD
Clofarabine—Haemoglobin—Prednisone—ankylosing spondylitis	0.000734	0.00229	CcSEcCtD
Clofarabine—Haemorrhage—Prednisone—ankylosing spondylitis	0.00073	0.00228	CcSEcCtD
Clofarabine—Erythema—Betamethasone—ankylosing spondylitis	0.00073	0.00228	CcSEcCtD
Clofarabine—Erythema—Dexamethasone—ankylosing spondylitis	0.00073	0.00228	CcSEcCtD
Clofarabine—Pancytopenia—Methotrexate—ankylosing spondylitis	0.000724	0.00226	CcSEcCtD
Clofarabine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000718	0.00224	CcSEcCtD
Clofarabine—Oedema—Prednisolone—ankylosing spondylitis	0.000714	0.00223	CcSEcCtD
Clofarabine—Neutropenia—Methotrexate—ankylosing spondylitis	0.000713	0.00222	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.000709	0.00221	CcSEcCtD
Clofarabine—Cough—Triamcinolone—ankylosing spondylitis	0.000702	0.00219	CcSEcCtD
Clofarabine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000697	0.00217	CcSEcCtD
Clofarabine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000695	0.00217	CcSEcCtD
Clofarabine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000693	0.00216	CcSEcCtD
Clofarabine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00069	0.00215	CcSEcCtD
Clofarabine—Myalgia—Triamcinolone—ankylosing spondylitis	0.000685	0.00214	CcSEcCtD
Clofarabine—Pneumonia—Methotrexate—ankylosing spondylitis	0.000684	0.00213	CcSEcCtD
Clofarabine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000683	0.00213	CcSEcCtD
Clofarabine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000683	0.00213	CcSEcCtD
Clofarabine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000681	0.00212	CcSEcCtD
Clofarabine—Infestation—Methotrexate—ankylosing spondylitis	0.00068	0.00212	CcSEcCtD
Clofarabine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00068	0.00212	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000679	0.00212	CcSEcCtD
Clofarabine—Flushing—Prednisone—ankylosing spondylitis	0.000678	0.00211	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000674	0.0021	CcSEcCtD
Clofarabine—Renal failure—Methotrexate—ankylosing spondylitis	0.000668	0.00208	CcSEcCtD
Clofarabine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000663	0.00207	CcSEcCtD
Clofarabine—Angiopathy—Prednisone—ankylosing spondylitis	0.000663	0.00207	CcSEcCtD
Clofarabine—Immune system disorder—Prednisone—ankylosing spondylitis	0.00066	0.00206	CcSEcCtD
Clofarabine—Oedema—Triamcinolone—ankylosing spondylitis	0.000657	0.00205	CcSEcCtD
Clofarabine—Infection—Triamcinolone—ankylosing spondylitis	0.000652	0.00203	CcSEcCtD
Clofarabine—Infection—Methylprednisolone—ankylosing spondylitis	0.000651	0.00203	CcSEcCtD
Clofarabine—Haematuria—Methotrexate—ankylosing spondylitis	0.000648	0.00202	CcSEcCtD
Clofarabine—Alopecia—Prednisone—ankylosing spondylitis	0.000645	0.00201	CcSEcCtD
Clofarabine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000643	0.00201	CcSEcCtD
Clofarabine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000643	0.002	CcSEcCtD
Clofarabine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000641	0.002	CcSEcCtD
Clofarabine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000641	0.002	CcSEcCtD
Clofarabine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000641	0.002	CcSEcCtD
Clofarabine—Mental disorder—Prednisone—ankylosing spondylitis	0.00064	0.002	CcSEcCtD
Clofarabine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000639	0.00199	CcSEcCtD
Clofarabine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000636	0.00198	CcSEcCtD
Clofarabine—Malnutrition—Prednisone—ankylosing spondylitis	0.000636	0.00198	CcSEcCtD
Clofarabine—Erythema—Prednisone—ankylosing spondylitis	0.000636	0.00198	CcSEcCtD
Clofarabine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000635	0.00198	CcSEcCtD
Clofarabine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000633	0.00198	CcSEcCtD
Clofarabine—Hypertension—Betamethasone—ankylosing spondylitis	0.00063	0.00197	CcSEcCtD
Clofarabine—Hypertension—Dexamethasone—ankylosing spondylitis	0.00063	0.00197	CcSEcCtD
Clofarabine—Myalgia—Dexamethasone—ankylosing spondylitis	0.000622	0.00194	CcSEcCtD
Clofarabine—Myalgia—Betamethasone—ankylosing spondylitis	0.000622	0.00194	CcSEcCtD
Clofarabine—Anxiety—Betamethasone—ankylosing spondylitis	0.000619	0.00193	CcSEcCtD
Clofarabine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000619	0.00193	CcSEcCtD
Clofarabine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000613	0.00191	CcSEcCtD
Clofarabine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000612	0.00191	CcSEcCtD
Clofarabine—Pain—Prednisolone—ankylosing spondylitis	0.000611	0.0019	CcSEcCtD
Clofarabine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00061	0.0019	CcSEcCtD
Clofarabine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000603	0.00188	CcSEcCtD
Clofarabine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000598	0.00187	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000598	0.00187	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000597	0.00186	CcSEcCtD
Clofarabine—Oedema—Betamethasone—ankylosing spondylitis	0.000596	0.00186	CcSEcCtD
Clofarabine—Oedema—Dexamethasone—ankylosing spondylitis	0.000596	0.00186	CcSEcCtD
Clofarabine—Infection—Dexamethasone—ankylosing spondylitis	0.000592	0.00185	CcSEcCtD
Clofarabine—Infection—Betamethasone—ankylosing spondylitis	0.000592	0.00185	CcSEcCtD
Clofarabine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00059	0.00184	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000588	0.00184	CcSEcCtD
Clofarabine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000588	0.00183	CcSEcCtD
Clofarabine—Anaemia—Prednisone—ankylosing spondylitis	0.000588	0.00183	CcSEcCtD
Clofarabine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000585	0.00183	CcSEcCtD
Clofarabine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000584	0.00182	CcSEcCtD
Clofarabine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000584	0.00182	CcSEcCtD
Clofarabine—Agitation—Prednisone—ankylosing spondylitis	0.000584	0.00182	CcSEcCtD
Clofarabine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000583	0.00182	CcSEcCtD
Clofarabine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000583	0.00182	CcSEcCtD
Clofarabine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000581	0.00181	CcSEcCtD
Clofarabine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000581	0.00181	CcSEcCtD
Clofarabine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000577	0.0018	CcSEcCtD
Clofarabine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000576	0.0018	CcSEcCtD
Clofarabine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000576	0.0018	CcSEcCtD
Clofarabine—Anorexia—Betamethasone—ankylosing spondylitis	0.000568	0.00177	CcSEcCtD
Clofarabine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000568	0.00177	CcSEcCtD
Clofarabine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000566	0.00177	CcSEcCtD
Clofarabine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000566	0.00177	CcSEcCtD
Clofarabine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000565	0.00176	CcSEcCtD
Clofarabine—Pain—Triamcinolone—ankylosing spondylitis	0.000562	0.00175	CcSEcCtD
Clofarabine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000557	0.00174	CcSEcCtD
Clofarabine—Hypotension—Betamethasone—ankylosing spondylitis	0.000557	0.00174	CcSEcCtD
Clofarabine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000554	0.00173	CcSEcCtD
Clofarabine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000551	0.00172	CcSEcCtD
Clofarabine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00055	0.00172	CcSEcCtD
Clofarabine—Hypertension—Prednisone—ankylosing spondylitis	0.000549	0.00171	CcSEcCtD
Clofarabine—Chills—Methotrexate—ankylosing spondylitis	0.000548	0.00171	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000543	0.00169	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000543	0.00169	CcSEcCtD
Clofarabine—Myalgia—Prednisone—ankylosing spondylitis	0.000541	0.00169	CcSEcCtD
Clofarabine—Arthralgia—Prednisone—ankylosing spondylitis	0.000541	0.00169	CcSEcCtD
Clofarabine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000541	0.00169	CcSEcCtD
Clofarabine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00054	0.00168	CcSEcCtD
Clofarabine—Anxiety—Prednisone—ankylosing spondylitis	0.000539	0.00168	CcSEcCtD
Clofarabine—Alopecia—Methotrexate—ankylosing spondylitis	0.000539	0.00168	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000538	0.00168	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000536	0.00167	CcSEcCtD
Clofarabine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000535	0.00167	CcSEcCtD
Clofarabine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000535	0.00167	CcSEcCtD
Clofarabine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000535	0.00167	CcSEcCtD
Clofarabine—Erythema—Methotrexate—ankylosing spondylitis	0.000531	0.00166	CcSEcCtD
Clofarabine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000531	0.00166	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000526	0.00164	CcSEcCtD
Clofarabine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000519	0.00162	CcSEcCtD
Clofarabine—Oedema—Prednisone—ankylosing spondylitis	0.000519	0.00162	CcSEcCtD
Clofarabine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000518	0.00162	CcSEcCtD
Clofarabine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000518	0.00162	CcSEcCtD
Clofarabine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000518	0.00162	CcSEcCtD
Clofarabine—Infection—Prednisone—ankylosing spondylitis	0.000515	0.00161	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000514	0.0016	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000514	0.0016	CcSEcCtD
Clofarabine—Back pain—Methotrexate—ankylosing spondylitis	0.000514	0.0016	CcSEcCtD
Clofarabine—Fatigue—Betamethasone—ankylosing spondylitis	0.000514	0.0016	CcSEcCtD
Clofarabine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000514	0.0016	CcSEcCtD
Clofarabine—Pain—Betamethasone—ankylosing spondylitis	0.00051	0.00159	CcSEcCtD
Clofarabine—Pain—Dexamethasone—ankylosing spondylitis	0.00051	0.00159	CcSEcCtD
Clofarabine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000509	0.00159	CcSEcCtD
Clofarabine—Tachycardia—Prednisone—ankylosing spondylitis	0.000506	0.00158	CcSEcCtD
Clofarabine—Skin disorder—Prednisone—ankylosing spondylitis	0.000504	0.00157	CcSEcCtD
Clofarabine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000502	0.00156	CcSEcCtD
Clofarabine—Anorexia—Prednisone—ankylosing spondylitis	0.000495	0.00154	CcSEcCtD
Clofarabine—Anaemia—Methotrexate—ankylosing spondylitis	0.000491	0.00153	CcSEcCtD
Clofarabine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000491	0.00153	CcSEcCtD
Clofarabine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000491	0.00153	CcSEcCtD
Clofarabine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000487	0.00152	CcSEcCtD
Clofarabine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000487	0.00152	CcSEcCtD
Clofarabine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000484	0.00151	CcSEcCtD
Clofarabine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000483	0.00151	CcSEcCtD
Clofarabine—Leukopenia—Methotrexate—ankylosing spondylitis	0.000476	0.00148	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000473	0.00147	CcSEcCtD
Clofarabine—Dizziness—Prednisolone—ankylosing spondylitis	0.000472	0.00147	CcSEcCtD
Clofarabine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000471	0.00147	CcSEcCtD
Clofarabine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000471	0.00147	CcSEcCtD
Clofarabine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000471	0.00147	CcSEcCtD
Clofarabine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000471	0.00147	CcSEcCtD
Clofarabine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000471	0.00147	CcSEcCtD
Clofarabine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00047	0.00147	CcSEcCtD
Clofarabine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000466	0.00145	CcSEcCtD
Clofarabine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000465	0.00145	CcSEcCtD
Clofarabine—Cough—Methotrexate—ankylosing spondylitis	0.000464	0.00145	CcSEcCtD
Clofarabine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000464	0.00145	CcSEcCtD
Clofarabine—Myalgia—Methotrexate—ankylosing spondylitis	0.000452	0.00141	CcSEcCtD
Clofarabine—Arthralgia—Methotrexate—ankylosing spondylitis	0.000452	0.00141	CcSEcCtD
Clofarabine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000451	0.00141	CcSEcCtD
Clofarabine—Rash—Prednisolone—ankylosing spondylitis	0.00045	0.0014	CcSEcCtD
Clofarabine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00045	0.0014	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000449	0.0014	CcSEcCtD
Clofarabine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000448	0.0014	CcSEcCtD
Clofarabine—Fatigue—Prednisone—ankylosing spondylitis	0.000447	0.0014	CcSEcCtD
Clofarabine—Headache—Prednisolone—ankylosing spondylitis	0.000447	0.0014	CcSEcCtD
Clofarabine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000434	0.00135	CcSEcCtD
Clofarabine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000433	0.00135	CcSEcCtD
Clofarabine—Infection—Methotrexate—ankylosing spondylitis	0.000431	0.00134	CcSEcCtD
Clofarabine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000428	0.00133	CcSEcCtD
Clofarabine—Asthenia—Betamethasone—ankylosing spondylitis	0.000427	0.00133	CcSEcCtD
Clofarabine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000427	0.00133	CcSEcCtD
Clofarabine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000425	0.00133	CcSEcCtD
Clofarabine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000425	0.00132	CcSEcCtD
Clofarabine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000424	0.00132	CcSEcCtD
Clofarabine—Nausea—Prednisolone—ankylosing spondylitis	0.000424	0.00132	CcSEcCtD
Clofarabine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000422	0.00131	CcSEcCtD
Clofarabine—Pruritus—Betamethasone—ankylosing spondylitis	0.000422	0.00131	CcSEcCtD
Clofarabine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000421	0.00131	CcSEcCtD
Clofarabine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000419	0.00131	CcSEcCtD
Clofarabine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000418	0.0013	CcSEcCtD
Clofarabine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000417	0.0013	CcSEcCtD
Clofarabine—Rash—Triamcinolone—ankylosing spondylitis	0.000414	0.00129	CcSEcCtD
Clofarabine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000414	0.00129	CcSEcCtD
Clofarabine—Anorexia—Methotrexate—ankylosing spondylitis	0.000413	0.00129	CcSEcCtD
Clofarabine—Rash—Methylprednisolone—ankylosing spondylitis	0.000413	0.00129	CcSEcCtD
Clofarabine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000413	0.00129	CcSEcCtD
Clofarabine—Headache—Triamcinolone—ankylosing spondylitis	0.000411	0.00128	CcSEcCtD
Clofarabine—Headache—Methylprednisolone—ankylosing spondylitis	0.00041	0.00128	CcSEcCtD
Clofarabine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00041	0.00128	CcSEcCtD
Clofarabine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00041	0.00128	CcSEcCtD
Clofarabine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000408	0.00127	CcSEcCtD
Clofarabine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000408	0.00127	CcSEcCtD
Clofarabine—Hypotension—Methotrexate—ankylosing spondylitis	0.000405	0.00126	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000395	0.00123	CcSEcCtD
Clofarabine—Dizziness—Betamethasone—ankylosing spondylitis	0.000394	0.00123	CcSEcCtD
Clofarabine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000394	0.00123	CcSEcCtD
Clofarabine—Nausea—Triamcinolone—ankylosing spondylitis	0.00039	0.00122	CcSEcCtD
Clofarabine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000389	0.00121	CcSEcCtD
Clofarabine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000389	0.00121	CcSEcCtD
Clofarabine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000387	0.00121	CcSEcCtD
Clofarabine—Somnolence—Methotrexate—ankylosing spondylitis	0.000386	0.0012	CcSEcCtD
Clofarabine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000382	0.00119	CcSEcCtD
Clofarabine—Vomiting—Betamethasone—ankylosing spondylitis	0.000379	0.00118	CcSEcCtD
Clofarabine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000379	0.00118	CcSEcCtD
Clofarabine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000377	0.00118	CcSEcCtD
Clofarabine—Rash—Betamethasone—ankylosing spondylitis	0.000376	0.00117	CcSEcCtD
Clofarabine—Rash—Dexamethasone—ankylosing spondylitis	0.000376	0.00117	CcSEcCtD
Clofarabine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000375	0.00117	CcSEcCtD
Clofarabine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000375	0.00117	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000374	0.00117	CcSEcCtD
Clofarabine—Fatigue—Methotrexate—ankylosing spondylitis	0.000374	0.00117	CcSEcCtD
Clofarabine—Headache—Dexamethasone—ankylosing spondylitis	0.000373	0.00116	CcSEcCtD
Clofarabine—Headache—Betamethasone—ankylosing spondylitis	0.000373	0.00116	CcSEcCtD
Clofarabine—Asthenia—Prednisone—ankylosing spondylitis	0.000372	0.00116	CcSEcCtD
Clofarabine—Pain—Methotrexate—ankylosing spondylitis	0.000371	0.00116	CcSEcCtD
Clofarabine—Pruritus—Prednisone—ankylosing spondylitis	0.000367	0.00114	CcSEcCtD
Clofarabine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000357	0.00111	CcSEcCtD
Clofarabine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000355	0.00111	CcSEcCtD
Clofarabine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000355	0.00111	CcSEcCtD
Clofarabine—Nausea—Dexamethasone—ankylosing spondylitis	0.000354	0.0011	CcSEcCtD
Clofarabine—Nausea—Betamethasone—ankylosing spondylitis	0.000354	0.0011	CcSEcCtD
Clofarabine—Dizziness—Prednisone—ankylosing spondylitis	0.000343	0.00107	CcSEcCtD
Clofarabine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000343	0.00107	CcSEcCtD
Clofarabine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000343	0.00107	CcSEcCtD
Clofarabine—Vomiting—Prednisone—ankylosing spondylitis	0.00033	0.00103	CcSEcCtD
Clofarabine—Rash—Prednisone—ankylosing spondylitis	0.000327	0.00102	CcSEcCtD
Clofarabine—Dermatitis—Prednisone—ankylosing spondylitis	0.000327	0.00102	CcSEcCtD
Clofarabine—Headache—Prednisone—ankylosing spondylitis	0.000325	0.00101	CcSEcCtD
Clofarabine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000319	0.000996	CcSEcCtD
Clofarabine—Asthenia—Methotrexate—ankylosing spondylitis	0.000311	0.00097	CcSEcCtD
Clofarabine—Nausea—Prednisone—ankylosing spondylitis	0.000308	0.000961	CcSEcCtD
Clofarabine—Pruritus—Methotrexate—ankylosing spondylitis	0.000307	0.000957	CcSEcCtD
Clofarabine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000297	0.000925	CcSEcCtD
Clofarabine—Dizziness—Methotrexate—ankylosing spondylitis	0.000287	0.000894	CcSEcCtD
Clofarabine—Vomiting—Methotrexate—ankylosing spondylitis	0.000276	0.00086	CcSEcCtD
Clofarabine—Rash—Methotrexate—ankylosing spondylitis	0.000273	0.000853	CcSEcCtD
Clofarabine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000273	0.000852	CcSEcCtD
Clofarabine—Headache—Methotrexate—ankylosing spondylitis	0.000272	0.000847	CcSEcCtD
Clofarabine—Nausea—Methotrexate—ankylosing spondylitis	0.000258	0.000803	CcSEcCtD
